Electronic healthcare records (EHR)
Describing Adult Heart Failure Patients – Assessment of Real-Life Data in Two Sites
Bulgaria
EU PAS number:
EUPAS1000000570
First published:
06/05/2025
StudyFinalised
Proton therapy for head and neck cancer therapy: A real-world data case study from Bulgaria
Bulgaria
EU PAS number:
EUPAS1000000569
First published:
06/05/2025
StudyFinalised
Real-world effectiveness of dabrafenib and trametinib in patients with BRAF-positive melanoma treated in routine Bulgarian clinical practice
Bulgaria
EU PAS number:
EUPAS1000000567
First published:
06/05/2025
StudyFinalised
Phenotyping Asthma Exacerbations in primary care: an electronic medical record study (PHASE)
United Kingdom
EU PAS number:
EUPAS1000000566
First published:
06/05/2025
StudyPlanned
Safety, tolerability, and efficacy of a dry extract from nettle leaves (Hox alpha) vs. NSAIDs in self-treatment of inflammatory joint pain in osteoarthritis. A propensity score-matched analysis of depersonalized 3-month data from the German Pain e-Registry - "Sipharo"
Germany
EU PAS number:
EUPAS1000000564
First published:
28/04/2025
StudyFinalised
FLAIR: Fostair vs Symbicort: CLinical effectiveness of anti-inflammatory reliever therapies (AIR): a non-inferiority study
United Kingdom
EU PAS number:
EUPAS1000000560
First published:
30/04/2025
StudyOngoing
Comparative Effectiveness of Ticagrelor vs. Prasugrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
Korea, Republic of
United States
EU PAS number:
EUPAS1000000551
First published:
24/04/2025
StudyOngoing
Association between previous biologic therapy exposure and incidence of life-threatening infections in patients with rheumatoid arthritis and psoriasis. A population-based cohort study.
Spain
EU PAS number:
EUPAS1000000543
First published:
09/04/2025
StudyPlanned
Assessing the impact of earlier access to biologics on remission and natural course of asthma (GLEAM)
Argentina
Belgium
Brazil
Bulgaria
Canada
Colombia
Denmark
Estonia
Greece
India
Ireland
Italy
Japan
Korea, Republic of
Kuwait
Mexico
Norway
Poland
Portugal
Saudi Arabia
Singapore
Spain
Taiwan
United Arab Emirates
United Kingdom
United States
EU PAS number:
EUPAS1000000530
First published:
28/03/2025
StudyOngoing
Post-Authorization Safety Study to Assess the Effectiveness of the Newly Implemented Risk Minimization Measures for Topiramate: Drug Utilization Study
France
Germany
Spain
Sweden
United Kingdom
EU PAS number:
EUPAS1000000494
First published:
20/03/2025
StudyPlanned